US Patent Issued to Regeneration Biomedical on Jan. 20 for "Wnt-activated adipose-derived stem cell apparatuses, methods and systems" (California Inventor)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,034, issued on Jan. 20, was assigned to Regeneration Biomedical Inc. (Newport Beach, Calif.).

"Wnt-activated adipose-derived stem cell apparatuses, methods and systems" was invented by Christopher Duma (Newport Beach, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The WNT-ACTIVATED ADIPOSE-DERIVED STEM CELL APPARATUSES, METHODS AND SYSTEMS (hereinafter "WAADSC") disclosed herein in various embodiments provide for production of an isolated and enriched population of mesenchymal stem cells that have an active Wnt signaling demonstrated by the elevated expression of Lgr5 marker and/or Nestin in more than 50% of the population. Such an autologous...